John F. Kuckelman
John F. Kuckelman is the legal director at Novo Nordisk, a leading global healthcare company specializing in diabetes care and chronic disease management. He recently made headlines by addressing the company's decision to sue competitor Eli Lilly for allegedly misleading marketing practices concerning their weight loss medications, asserting that pharmaceutical companies have a responsibility to provide accurate and truthful information in their public claims.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 7.00 | 0.04% | +0% | 67,886,011 | 28,180 | $2,700,000 | 1,121$ |
| Denmark | 1 | 7.00 | 0.08% | +0% | 5,792,202 | 4,775 | $350,000 | 289$ |
| Totals | 2 | 73,678,213 | 32,955 | $3,050,000 | 1,410$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
John F. Kuckelman is the senior vice president and group general counsel for Novo Nordisk.
7
Denmark:
John F. Kuckelman is the legal director at Novo Nordisk.
7